64 related articles for article (PubMed ID: 12404879)
21. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
Sawutz DG; Sylvestre D; Homcy CJ
J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, alpha-adrenoceptors affinity and alpha 1-adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives.
Marona H; Kubacka M; Filipek B; Siwek A; Dybała M; Szneler E; Pociecha T; Gunia A; Waszkielewicz AM
Pharmazie; 2011 Oct; 66(10):733-9. PubMed ID: 22026152
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.
Gibson RE; Rzeszotarski WJ; Komai T; Reba RC; Eckelman WC
J Pharmacol Exp Ther; 1979 Apr; 209(1):153-61. PubMed ID: 34714
[No Abstract] [Full Text] [Related]
24. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.
Fraundorfer PF; Lezama EJ; Salazar-Bookaman MM; Fertel RH; Miller DD; Feller DR
Chirality; 1994; 6(2):76-85. PubMed ID: 7911313
[TBL] [Abstract][Full Text] [Related]
25. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
Pauwels PJ; Gommeren W; Van Lommen G; Janssen PA; Leysen JE
Mol Pharmacol; 1988 Dec; 34(6):843-51. PubMed ID: 2462161
[TBL] [Abstract][Full Text] [Related]
26. Rapid eye movement sleep deprivation-induced down-regulation of beta-adrenergic receptors in the rat brainstem and hippocampus.
Pedrazzoli M; Benedito MA
Pharmacol Biochem Behav; 2004 Sep; 79(1):31-6. PubMed ID: 15388281
[TBL] [Abstract][Full Text] [Related]
27. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
Scarpace PJ; Abrass IB
J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors.
Minneman KP; Weiland GA; Molinoff PB
Mol Pharmacol; 1980 Jan; 17(1):1-7. PubMed ID: 6247636
[No Abstract] [Full Text] [Related]
29. Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
Bouzoubaa M; Leclerc G; Decker N; Schwartz J; Andermann G
J Med Chem; 1984 Oct; 27(10):1291-4. PubMed ID: 6148422
[TBL] [Abstract][Full Text] [Related]
30. A competitive receptor binding radioassay for beta-1 and beta-2 adrenergic agents.
Hussain MN; Culbreth W; Dalrymple R; Fung C; Ricks C
Proc Soc Exp Biol Med; 1987 May; 185(1):89-92. PubMed ID: 2883662
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
McClure DE; Baldwin JJ; Randall WC; Lyon TF; Mensler K; Lundell GF; Raab AW; Gross D; Risley EA; Sweet CS; Williams M
J Med Chem; 1983 May; 26(5):649-57. PubMed ID: 6132999
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of a photoaffinity probe for the beta-adrenergic receptor.
Darfler FJ; Marinetti GV
Biochem Biophys Res Commun; 1977 Nov; 79(1):1-7. PubMed ID: 200234
[No Abstract] [Full Text] [Related]
33. Modulation of β-adrenergic receptor in rat lung after gamma irradiation.
Qiang YG; Liao YH; Zhang XP; Li J; Huang Z
J Xray Sci Technol; 2014; 22(2):165-73. PubMed ID: 24699345
[TBL] [Abstract][Full Text] [Related]
34. Thyroid hormone modulation of agonist--beta-adrenergic receptor interactions in the rat heart.
Stiles GL; Lefkowitz RJ
Life Sci; 1981 Jun; 28(22):2529-36. PubMed ID: 6114379
[No Abstract] [Full Text] [Related]
35. Synthesis and beta-adrenergic properties of (Z)-N-[3-(alkylamino)-2-hydroxypropylidene](aryl-methyloxy)amines: effects of the configuration around the methyloxyiminomethyl (MOIM) double bond on the biopharmacological properties of MOIM-type beta-blocking agents.
Balsamo A; Breschi MC; Chiellini G; Lapucci A; Lazzeri N; Macchia M; Martinelli A; Micali E; Nencetti S; Rossello A
Bioorg Med Chem; 1998 Nov; 6(11):2151-60. PubMed ID: 9881105
[TBL] [Abstract][Full Text] [Related]
36. beta-Adrenergic antagonists with multiple pharmacophores: persistent blockade of receptors.
Pitha J; Milecki J; Czajkowska T; Kusiak JW
J Med Chem; 1983 Jan; 26(1):7-11. PubMed ID: 6131128
[TBL] [Abstract][Full Text] [Related]
37. Tentative identification of beta-adrenoreceptor subunts.
Atlas D; Levitzki A
Nature; 1978 Mar; 272(5651):370-1. PubMed ID: 204872
[No Abstract] [Full Text] [Related]
38. Monoclonal antibodies to beta-adrenergic receptors: use in purification and molecular characterization of beta receptors.
Fraser CM; Venter JC
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7034-8. PubMed ID: 6261236
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 4-(1-oxo-isoindoline) and 4-(5,6-dimethoxy-1-oxo-isoindoline)-substituted phenoxypropanolamines and their beta1-, beta2-adrenergic receptor binding studies.
Jindal DP; Singh B; Coumar MS; Bruni G; Massarelli P
Bioorg Chem; 2005 Aug; 33(4):310-24. PubMed ID: 15975623
[TBL] [Abstract][Full Text] [Related]
40. (1,4-Benzothiazinyloxy)alkylpiperazine derivatives as potential antihypertensive agents.
Cecchetti V; Schiaffella F; Tabarrini O; Fravolini A
Bioorg Med Chem Lett; 2000 Mar; 10(5):465-8. PubMed ID: 10743949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
